© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Infarct scar: a dynamic tissue
Division of Cardiovascular Diseases, Department of Internal Medicine, University of Tennessee, Memphis College of Medicine, Rm. 353 Dobbs Research Institute, 951 Court Avenue, Memphis, TN 38163, USA
* Corresponding author. Tel.: +1-901-448-5759; fax: +1-901-448-8084 ktweber{at}utmem.edu
Infarct scar, a requisite to the rebuilding of necrotic myocardium following myocardial infarction (MI), has long been considered inert. Earlier morphologic studies suggested healing at the infarct site was complete within 6–8 weeks following MI and resultant scar tissue, albeit necessary, was acellular and simply fibrillar collagen. Utilizing molecular and cellular biologic technologies, recent studies indicate otherwise. Infarct scar is composed of phenotypically transformed fibroblast-like cells, termed myofibroblasts (myoFb) because they express alpha-smooth muscle actin (
-SMA) and these microfilaments confer contractile behavior in response to various peptides and amines. These cells are nourished by a neovasculature and are persistent at the MI site, where they are metabolically active expressing components requisite to angiotensin (Ang) peptide generation, including converting enzyme, receptors for AngII and transforming growth factor (TGF)-β1. They continue to elaborate fibrillar type I collagen. Their generation of these peptides contribute to ongoing scar tissue collagen turnover and to fibrous tissue formation of noninfarcted myocardium. Infarct scar contraction accounts for its thinning and its tonus may contribute to abnormal ventricular chamber stiffness with diastolic dysfunction. Infarct scar is a dynamic tissue: cellular, vascularized, metabolically active and contractile. Pharmacologic interventions with angiotensin converting enzyme inhibitor or AT1 receptor antagonist has proven effective in attenuating scar tissue metabolic activity and minimizing adverse accumulation of fibrous tissue in noninfarcted myocardium.
KEYWORDS Angiotensin; Fibrosis; Growth factors; Infarction
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Takemura, M. Nakagawa, H. Kanamori, S. Minatoguchi, and H. Fujiwara Benefits of reperfusion beyond infarct size limitation Cardiovasc Res, July 15, 2009; 83(2): 269 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Okada, G. Takemura, K.-i. Kosai, A. Tsujimoto, M. Esaki, T. Takahashi, S. Nagano, H. Kanamori, S. Miyata, Y. Li, et al. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H616 - H626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Vela, G. V. Silva, J. A.R. Assad, A. L.S. Sousa, S. Coulter, M. R. Fernandes, E. C. Perin, J. T. Willerson, and L. M. Buja Histopathological Study of Healing After Allogenic Mesenchymal Stem Cell Delivery in Myocardial Infarction in Dogs J. Histochem. Cytochem., February 1, 2009; 57(2): 167 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wang, D.-Q. Wu, X.-J. Jiang, X.-Z. Zhang, X.-Y. Li, J.-F. Zhang, Z.-B. Zheng, R. Zhuo, H. Jiang, and C. Huang Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling Eur J Heart Fail, January 1, 2009; 11(1): 14 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W.M. van den Borne, S. Isobe, J. W. Verjans, A. Petrov, D. Lovhaug, P. Li, H. R. Zandbergen, Y. Ni, P. Frederik, J. Zhou, et al. Molecular Imaging of Interstitial Alterations in Remodeling Myocardium After Myocardial Infarction J. Am. Coll. Cardiol., December 9, 2008; 52(24): 2017 - 2028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mukherjee, J. A. Zavadzkas, S. M. Saunders, J. E. McLean, L. B. Jeffords, C. Beck, R. E. Stroud, A. M. Leone, C. N. Koval, W. T. Rivers, et al. Targeted Myocardial Microinjections of a Biocomposite Material Reduces Infarct Expansion in Pigs Ann. Thorac. Surg., October 1, 2008; 86(4): 1268 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakagawa, G. Takemura, H. Kanamori, K. Goto, R. Maruyama, A. Tsujimoto, T. Ohno, H. Okada, A. Ogino, M. Esaki, et al. Mechanisms by Which Late Coronary Reperfusion Mitigates Postinfarction Cardiac Remodeling Circ. Res., July 3, 2008; 103(1): 98 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Prech, S. Grajek, A. Marszalek, M. Lesiak, M. Jemielity, A. Araszkiewicz, T. Mularek-Kubzdela, and A. Cieslinski Chronic infarct-related artery occlusion is associated with a reduction in capillary density. Effects on infarct healing Eur J Heart Fail, June 1, 2006; 8(4): 373 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T Weber and Yao Sun Recruitable ACE and tissue repair in the infarcted heart Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 295 - 303. [PDF]
|
|